Copyright Reports & Markets. All rights reserved.

Global Gastrointestinal Therapeutics and Diagnostics Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Diagnostics
    • 1.2.3 Therapeutics
  • 1.3 Market by Application
    • 1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Gastroenteritis
    • 1.3.3 GI Bleeding
    • 1.3.4 Irritable Bowel Syndrome
    • 1.3.5 Peptic Ulcer Disease (PUD)
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Perspective (2016-2027)
  • 2.2 Gastrointestinal Therapeutics and Diagnostics Growth Trends by Regions
    • 2.2.1 Gastrointestinal Therapeutics and Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Gastrointestinal Therapeutics and Diagnostics Historic Market Share by Regions (2016-2021)
    • 2.2.3 Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Regions (2022-2027)
  • 2.3 Gastrointestinal Therapeutics and Diagnostics Industry Dynamic
    • 2.3.1 Gastrointestinal Therapeutics and Diagnostics Market Trends
    • 2.3.2 Gastrointestinal Therapeutics and Diagnostics Market Drivers
    • 2.3.3 Gastrointestinal Therapeutics and Diagnostics Market Challenges
    • 2.3.4 Gastrointestinal Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue
    • 3.1.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue (2016-2021)
    • 3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2016-2021)
  • 3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Gastrointestinal Therapeutics and Diagnostics Revenue
  • 3.4 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio
    • 3.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics and Diagnostics Revenue in 2020
  • 3.5 Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Area Served
  • 3.6 Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type

  • 4.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Type (2016-2021)
  • 4.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2022-2027)

5 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application

  • 5.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Application (2016-2021)
  • 5.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2016-2027)
  • 6.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type
    • 6.2.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2021)
    • 6.2.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2022-2027)
    • 6.2.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2027)
  • 6.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application
    • 6.3.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2021)
    • 6.3.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2022-2027)
    • 6.3.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2027)
  • 6.4 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country
    • 6.4.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2016-2021)
    • 6.4.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2016-2027)
  • 7.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type
    • 7.2.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2021)
    • 7.2.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2022-2027)
    • 7.2.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2027)
  • 7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application
    • 7.3.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2021)
    • 7.3.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2022-2027)
    • 7.3.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2027)
  • 7.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country
    • 7.4.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2016-2021)
    • 7.4.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size (2016-2027)
  • 8.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Type
    • 8.2.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Application
    • 8.3.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region
    • 8.4.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size (2016-2027)
  • 9.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Type
    • 9.2.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2021)
    • 9.2.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2022-2027)
    • 9.2.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2027)
  • 9.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Application
    • 9.3.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2021)
    • 9.3.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2022-2027)
    • 9.3.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2027)
  • 9.4 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country
    • 9.4.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2016-2021)
    • 9.4.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2016-2027)
  • 10.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type
    • 10.2.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application
    • 10.3.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country
    • 10.4.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Introduction
    • 11.1.4 Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2016-2021)
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 AstraZeneca
    • 11.2.1 AstraZeneca Company Details
    • 11.2.2 AstraZeneca Business Overview
    • 11.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Introduction
    • 11.2.4 AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2016-2021)
    • 11.2.5 AstraZeneca Recent Development
  • 11.3 Eisai
    • 11.3.1 Eisai Company Details
    • 11.3.2 Eisai Business Overview
    • 11.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Introduction
    • 11.3.4 Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2016-2021)
    • 11.3.5 Eisai Recent Development
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Company Details
    • 11.4.2 Johnson & Johnson Business Overview
    • 11.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Introduction
    • 11.4.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2016-2021)
    • 11.4.5 Johnson & Johnson Recent Development
  • 11.5 Salix Pharmaceuticals
    • 11.5.1 Salix Pharmaceuticals Company Details
    • 11.5.2 Salix Pharmaceuticals Business Overview
    • 11.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Introduction
    • 11.5.4 Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2016-2021)
    • 11.5.5 Salix Pharmaceuticals Recent Development
  • 11.6 Takeda Pharmaceutical Company
    • 11.6.1 Takeda Pharmaceutical Company Company Details
    • 11.6.2 Takeda Pharmaceutical Company Business Overview
    • 11.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Introduction
    • 11.6.4 Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2016-2021)
    • 11.6.5 Takeda Pharmaceutical Company Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Gastrointestinal Therapeutics and Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Diagnostics
    Therapeutics

    Segment by Application
    Gastroenteritis
    GI Bleeding
    Irritable Bowel Syndrome
    Peptic Ulcer Disease (PUD)
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Abbott Laboratories
    AstraZeneca
    Eisai
    Johnson & Johnson
    Salix Pharmaceuticals
    Takeda Pharmaceutical Company
    Johnson & Johnson

    Buy now